4//SEC Filing
King Rachel K. 4
Accession 0001209191-23-051390
CIK 0001253689other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:05 PM ET
Size
7.6 KB
Accession
0001209191-23-051390
Insider Transaction Report
Form 4
King Rachel K.
DirectorPresident, CEO
Transactions
- Award
Common stock
2023-09-30$1.50/sh+6,667$10,001→ 507,622 total
Holdings
- 45,741(indirect: By Spouse)
Common stock
- 7,500(indirect: By LLC)
Common stock
- 92,401(indirect: By Trust)
Common stock
Footnotes (3)
- [F1]These shares were issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board retainer fees of $10,000.
- [F2]The reporting person is co-manager of this entity. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- [F3]These shares are held by family trusts, for which Ms. King serves as trustee, as follows: 1,741 shares are held by The Connor A. King 1988 Trust, 1,741 shares are held by The Langley C. King 1990 Trust, 8,796 shares are held by the 1995 Connor A. King Trust, 8,796 shares are held by the 1995 Langley C. King Trust, 23,301 shares are held by The Connor King 2013 GRAT, 23,301 shares are held by The Langley C. King 2013 GRAT and 24,725 shares are held by The Rachel K. King 2016 GRAT.
Documents
Issuer
GLYCOMIMETICS INC
CIK 0001253689
Entity typeother
Related Parties
1- filerCIK 0001589712
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:05 PM ET
- Size
- 7.6 KB